Literature DB >> 30776694

Revealing quinquennial anticancer journey of morpholine: A SAR based review.

Fatima Arshad1, Mohemmed Faraz Khan1, Wasim Akhtar1, Mohammad Mumtaz Alam1, Lalit Mohan Nainwal1, Sumit Kumar Kaushik1, Mymoona Akhter1, Suhel Parvez2, Syed Misbahul Hasan3, Mohammad Shaquiquzzaman4.   

Abstract

Morpholine, a six-membered heterocycle containing one nitrogen and one oxygen atom, is a moiety of great significance. It forms an important intermediate in many industrial and organic syntheses. Morpholine containing drugs are of high therapeutic value. Its wide array of pharmacological activity includes anti-diabetic, anti-emetic, growth stimulant, anti-depressant, bronchodilator and anticancer. Multi-drug resistance in cancer cases have emerged in the last few years and have led to the failure of many chemotherapeutic drugs. Newer treatment methods and drugs are being developed to overcome this problem. Target based drug discovery is an effective method to develop novel anticancer drugs. To develop newer drugs, previously reported work needs to be studied. Keeping this in mind, last five year's literature on morpholine used as anticancer agents has been reviewed and summarized in the paper herein.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticancer; Heterocycle; Morpholine; Structure activity relationship (SAR); Targeted-therapy

Mesh:

Substances:

Year:  2019        PMID: 30776694     DOI: 10.1016/j.ejmech.2019.02.015

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Expanding the biological utility of bis-NHC gold(i) complexes through post synthetic carbamate conjugation.

Authors:  Sajal Sen; Yue Li; Vincent Lynch; Kuppuswamy Arumugam; Jonathan L Sessler; Jonathan F Arambula
Journal:  Chem Commun (Camb)       Date:  2019-08-29       Impact factor: 6.222

Review 2.  Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021).

Authors:  Ashima Dhiman; Rupam Sharma; Rajesh K Singh
Journal:  Acta Pharm Sin B       Date:  2022-04-01       Impact factor: 14.903

3.  Synthesis of Morpholine-, Piperidine-, and N-Substituted Piperazine-Coupled 2-(Benzimidazol-2-yl)-3-arylquinoxalines as Novel Potent Antitumor Agents.

Authors:  Vakhid A Mamedov; Nataliya A Zhukova; Alexandra D Voloshina; Victor V Syakaev; Tat'yana N Beschastnova; Anna P Lyubina; Syumbelya K Amerhanova; Aida I Samigullina; Aidar T Gubaidullin; Daina N Buzyurova; Il Dar Kh Rizvanov; Oleg G Sinyashin
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-01

4.  Occurrence of Morpholine in Central Nervous System Drug Discovery.

Authors:  Elena Lenci; Lorenzo Calugi; Andrea Trabocchi
Journal:  ACS Chem Neurosci       Date:  2021-01-18       Impact factor: 4.418

5.  Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer's Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis.

Authors:  Sumera Zaib; Rubina Munir; Muhammad Tayyab Younas; Naghmana Kausar; Aliya Ibrar; Sehar Aqsa; Noorma Shahid; Tahira Tasneem Asif; Hashem O Alsaab; Imtiaz Khan
Journal:  Molecules       Date:  2021-10-30       Impact factor: 4.411

6.  Synthesis and In Vitro Activity of Novel Melphalan Analogs in Hematological Malignancy Cells.

Authors:  Anastazja Poczta; Piotr Krzeczyński; Joanna Tobiasz; Aneta Rogalska; Arkadiusz Gajek; Agnieszka Marczak
Journal:  Int J Mol Sci       Date:  2022-02-03       Impact factor: 5.923

7.  DBU mediated one-pot synthesis of triazolo triazines via Dimroth type rearrangement.

Authors:  Ab Majeed Ganai; Tabasum Khan Pathan; Nisar Sayyad; Babita Kushwaha; Narva Deshwar Kushwaha; Andreas G Tzakos; Rajshekhar Karpoormath
Journal:  RSC Adv       Date:  2022-01-12       Impact factor: 3.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.